Arrowhead Pharmaceuticals, Inc. (ARWR)
67.65
-1.18
(-1.71%)
USD |
NASDAQ |
Dec 10, 09:36
Arrowhead Pharmaceuticals Total Liabilities (Quarterly): 947.02M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 2.173B |
| Ionis Pharmaceuticals, Inc. | 2.415B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Amgen, Inc. | 80.52B |
| Novartis AG | 62.54B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.450B |
| Shareholders Equity (Quarterly) | 466.05M |
| Debt to Equity Ratio | 1.574 |
| Current Ratio | 4.863 |
| Net Debt Paydown Yield | -1.19% |